tiprankstipranks
Sosei Group Corporation (JP:4565)
:4565
Japanese Market
4565
Sosei Group
RESEARCH TOOLSreports
Want to see JP:4565 full AI Analyst Report?

Sosei Group (4565) Stock News & Sentiment

3 Followers
Nxera Pharma Secures Third AbbVie Milestone in Neurology Collaboration
Premium
Company Announcements
Nxera Pharma Secures Third AbbVie Milestone in Neurology Collaboration
9d ago
Nxera Pharma Issues New Shares to Fund Japan Employee Stock Plan and Expand RSU Program
Premium
Company Announcements
Nxera Pharma Issues New Shares to Fund Japan Employee Stock Plan and Expand RSU Program
14d ago
Nxera Wins Taiwan Approval for QUVIVIQ Insomnia Drug, Eyes 2026 Launch
Premium
Company Announcements
Nxera Wins Taiwan Approval for QUVIVIQ Insomnia Drug, Eyes 2026 Launch
15d ago
Nxera Wins US$22.5m Milestone as Neurocrine Starts Phase 2 Schizophrenia Trial
Premium
Company Announcements
Nxera Wins US$22.5m Milestone as Neurocrine Starts Phase 2 Schizophrenia Trial
17d ago
Nxera Pharma Hits Second Milestone in Lilly Metabolic Disease Partnership
Premium
Company Announcements
Nxera Pharma Hits Second Milestone in Lilly Metabolic Disease Partnership
21d ago
Lilly’s Centessa Deal Highlights Nxera Pharma’s GPCR Platform Strength
Premium
Company Announcements
Lilly’s Centessa Deal Highlights Nxera Pharma’s GPCR Platform Strength
29d ago
Nxera Pharma Refreshes Board While Maintaining Core Leadership Team
Premium
Company Announcements
Nxera Pharma Refreshes Board While Maintaining Core Leadership Team
1M ago
More JP:4565 News >

4565 News on the Web

Nxera Pharma Issues New Shares to Fund Japan Employee Stock Plan and Expand RSU Program
TipRanks News
Bullish
Nxera Pharma's QUVIVIQ Receives Approval In Taiwan For The Treatment Of Insomnia
rttnews
Neutral
Nxera Wins Taiwan Approval for QUVIVIQ Insomnia Drug, Eyes 2026 Launch
TipRanks News
Neutral
Nxera Wins US$22.5m Milestone as Neurocrine Starts Phase 2 Schizophrenia Trial
TipRanks News
Neutral
Nxera Pharma Hits Second Milestone in Lilly Metabolic Disease Partnership
TipRanks News
Neutral
Nxera Pharma Refreshes Board While Maintaining Core Leadership Team
TipRanks News
Neutral
Nxera Pharma Secures $3 Million Milestone Payment from Centessa
TipRanks News
Neutral
Nxera Pharma Co Files South Korea Marketing Application For Daridorexant
rttnews
Bullish

News Score - Last 7 Days

Neutral
JP:4565
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4565’s Media Buzz Sentiment?
3 articles about JP:4565 were published this week. In an average week, 1.5 articles are published.
    What is JP:4565’s weekly average amount of articles?
    In an average week, 1.5 articles about JP:4565 are published.
      What is JP:4565’s News Sentiment?
      100% of articles about JP:4565 were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week